Amphion Innovations PLC Director dealing (5371B)
January 10 2018 - 12:09PM
UK Regulatory
TIDMAMP
RNS Number : 5371B
Amphion Innovations PLC
10 January 2018
AMPHION INNOVATIONS PLC
("Amphion" or "the Company")
Directors' Dealings
London and New York, 10 January 2018 - Amphion Innovations plc
(AIM: AMP), the developer of medical, life science, and technology
businesses, announces that on 5 January 2018 it granted options
over ordinary shares in the Company ("Options") to certain of its
directors as follows:
Director Amount Strike Vesting
Price
---------------------- -------- ----------- -----------------------
Richard Mansell-Jones 563,000 1.94 pence Over one year starting
as of 1 August
2017
---------------------- -------- ----------- -----------------------
Miroslaw Izienicki 375,000 1.94 pence Over one year starting
as of 1 August
2017
---------------------- -------- ----------- -----------------------
All Options commence vesting backdated from 1 August 2017.
The strike price is based on the closing price on 4 January
2018, and the Options are exercisable on the date of vesting.
Authority for the allotment of ordinary shares under the Share
Option Scheme was approved as a part of the Company's Annual
General Meeting.
In addition to the above Options allocation, the Company has
issued 799,562 ordinary shares in the Company ("New Ordinary
Shares"), representing 0.38% of the enlarged issued share capital,
to certain of its Board members (current and former) in payment of
directors' fees due them. The issue of Ordinary Shares is
calculated based on the closing mid-market price for the five days
leading up to the close on 4 January 2018. Following this issue the
current directors' shareholdings in the Company are as follows:
Director Number of Total Shareholding Percentage
New Ordinary of
Shares Voting Rights
----------------------- -------------- ------------------- ---------------
Miroslaw Izienicki 193,791 795,280 0.379%
----------------------- -------------- ------------------- ---------------
Richard Mansell-Jones 558,896 4,344,426 2.069%
----------------------- -------------- ------------------- ---------------
Gerard Moufflet
(former director) 46,875 1,320,833 0.629%
----------------------- -------------- ------------------- ---------------
Admission of the 799,562 New Ordinary Shares, ranking pari passu
with the existing ordinary shares, to trading on AIM is expected on
17 January 2018. Following the issue and allotment of the New
Ordinary Shares, the total issued share capital of the Company will
increase to 209,975,450 ordinary shares with each share holding one
voting right. This figure may be used by shareholders in the
Company as the denominator for the calculation by which they will
determine if they are required to notify their interest in, or a
change to their interest in, the share capital of the Company under
the Financial Conduct Authority's Disclosure and Transparency
Rules.
This announcement contains inside information for the purposes
of Article 7 of Regulation (EU) No 596/2014 ("MAR").
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS
DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY
ASSOCIATED WITH THEM
1 Details of the person discharging managerial
responsibilities/person closely associated
=== ===============================================================
a) Name Richard Mansell-Jones
=== =============================== ==============================
2 Reason for the notification
=== ===============================================================
a) Position/status Chairman and PDMR
=== =============================== ==============================
b) Initial notification/Amendment Initial notification
=== =============================== ==============================
3 Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
=== ===============================================================
a) Name Amphion Innovations plc
=== =============================== ==============================
b) LEI 213800M7MTE2W2P6C104
=== =============================== ==============================
4 Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
=== ===============================================================
a) Description Ordinary Shares
of the financial
instrument,
type of instrument
=== =============================== ==============================
b) Nature of the Richard Mansell-Jones has
transaction received new Ordinary Shares
in lieu of fees
=== =============================== ==============================
c) Price(s) and 558,896 Ordinary Shares
volume(s)
=== =============================== ==============================
d) Aggregated information
- Aggregated N/A (Single transaction)
volume
- Price
=== =============================== ==============================
e) Date of the 5 January 2018
transaction
=== =============================== ==============================
f) Place of the Outside a trading venue
transaction
=== =============================== ==============================
1 Details of the person discharging managerial
responsibilities/person closely associated
=== =================================================================
a) Name Miroslaw Izienicki
=== =============================== ================================
2 Reason for the notification
=== =================================================================
a) Position/status Non-executive Director and
PDMR
=== =============================== ================================
b) Initial notification/Amendment Initial notification
=== =============================== ================================
3 Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
=== =================================================================
a) Name Amphion Innovations plc
=== =============================== ================================
b) LEI 213800M7MTE2W2P6C104
=== =============================== ================================
4 Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
=== =================================================================
a) Description Ordinary Shares
of the financial
instrument,
type of instrument
=== =============================== ================================
b) Nature of the Miroslaw Izienicki has received
transaction new Ordinary Shares in lieu
of fees
=== =============================== ================================
c) Price(s) and 193,791 Ordinary Shares
volume(s)
=== =============================== ================================
d) Aggregated information
- Aggregated N/A (Single transaction)
volume
- Price
=== =============================== ================================
e) Date of the 5 January 2018
transaction
=== =============================== ================================
f) Place of the Outside a trading venue
transaction
=== =============================== ================================
1 Details of the person discharging managerial
responsibilities/person closely associated
=== =============================================================
a) Name Richard Mansell-Jones
=== =============================== ============================
2 Reason for the notification
=== =============================================================
a) Position/status Chairman and PDMR
=== =============================== ============================
b) Initial notification/Amendment Initial notification
=== =============================== ============================
3 Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
=== =============================================================
a) Name Amphion Innovations plc
=== =============================== ============================
b) LEI 213800M7MTE2W2P6C104
=== =============================== ============================
4 Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
=== =============================================================
a) Description Options to acquire Ordinary
of the financial Shares
instrument,
type of instrument
=== =============================== ============================
b) Nature of the Grant of options to acquire
transaction Ordinary Shares
=== =============================== ============================
c) Price(s) and Price(s) Volume(s)
volume(s) --------- ----------
1.94p 563,000
--------- ----------
=== =============================== ============================
d) Aggregated information
- Aggregated N/A (Single transaction)
volume
- Price
=== =============================== ============================
e) Date of the 5 January 2018
transaction
=== =============================== ============================
f) Place of the Outside a trading venue
transaction
=== =============================== ============================
1 Details of the person discharging managerial
responsibilities/person closely associated
=== =============================================================
a) Name Miroslaw Izienicki
=== =============================== ============================
2 Reason for the notification
=== =============================================================
a) Position/status Non-executive Director and
PDMR
=== =============================== ============================
b) Initial notification/Amendment Initial notification
=== =============================== ============================
3 Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
=== =============================================================
a) Name Amphion Innovations plc
=== =============================== ============================
b) LEI 213800M7MTE2W2P6C104
=== =============================== ============================
4 Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
=== =============================================================
a) Description Options to acquire Ordinary
of the financial Shares
instrument,
type of instrument
=== =============================== ============================
b) Nature of the Grant of options to acquire
transaction Ordinary Shares
=== =============================== ============================
c) Price(s) and Price(s) Volume(s)
volume(s) --------- ----------
1.94p 375,000
--------- ----------
=== =============================== ============================
d) Aggregated information
- Aggregated N/A (Single transaction)
volume
- Price
=== =============================== ============================
e) Date of the 5 January 2018
transaction
=== =============================== ============================
f) Place of the Outside a trading venue
transaction
=== =============================== ============================
For further information please contact:
Amphion Innovations Tel: +1 (212) 210 6224
Charlie Morgan
Panmure Gordon (UK) Limited (Nominated Tel: +44 (0)20
Adviser and Corporate Broker) 7886 2500
Freddy Crossley / Ryan McCarthy
(Corporate Finance)
Charlie Leigh-Pemberton
(Corporate Broking)
Northland Capital Partners Tel: +44 (0)20 3861
Limited (Joint Corporate Broker) 6625
Patrick Claridge / David
Hignell (Corporate Finance)
John Howes (Corporate
Broking)
Walbrook PR Tel: +44 (0)20 7933 8780
or
Anna Dunphy / Paul McManus amphion@walbrookpr.com
About Amphion Innovations plc
Amphion Innovations is a developer of medical, life science and
technology businesses. We use our extensive experience in company
building to invest and build shareholder value in high growth
companies in the US and UK. Amphion has significant shareholding in
7 Partner Companies developing proven technologies targeting
substantial commercial marketplaces. The Amphion model has been
refined to optimise the commercialisation of patents and other
intellectual property within the Partner Companies. The Partner
Companies collectively own or control over 200 separately
identified pieces of intellectual property, a number which grows
rapidly each year.
On the web: www.amphionplc.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHDBLFFVFFBBBV
(END) Dow Jones Newswires
January 10, 2018 12:09 ET (17:09 GMT)
Amphion Innovations (LSE:AMP)
Historical Stock Chart
From Mar 2024 to Apr 2024
Amphion Innovations (LSE:AMP)
Historical Stock Chart
From Apr 2023 to Apr 2024
